X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (11616) 11616
Newsletter (308) 308
Newspaper Article (174) 174
Magazine Article (92) 92
Book Chapter (12) 12
Government Document (7) 7
Dissertation (6) 6
Publication (4) 4
Book Review (2) 2
Conference Proceeding (2) 2
Streaming Video (2) 2
Web Resource (2) 2
Book / eBook (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (8647) 8647
male (5731) 5731
female (5135) 5135
albuterol - administration & dosage (4131) 4131
albuterol - therapeutic use (3934) 3934
asthma - drug therapy (3801) 3801
adult (3525) 3525
albuterol (3468) 3468
middle aged (2872) 2872
asthma (2789) 2789
albuterol - pharmacology (2679) 2679
administration, inhalation (2498) 2498
respiratory system (2367) 2367
index medicus (2121) 2121
bronchodilator agents - administration & dosage (2050) 2050
albuterol - analogs & derivatives (1992) 1992
bronchodilator agents - therapeutic use (1823) 1823
aged (1761) 1761
salbutamol (1737) 1737
salmeterol xinafoate (1731) 1731
adolescent (1728) 1728
double-blind method (1714) 1714
animals (1690) 1690
child (1634) 1634
asthma - physiopathology (1443) 1443
pharmacology & pharmacy (1405) 1405
nebulizers and vaporizers (1308) 1308
albuterol - adverse effects (1136) 1136
treatment outcome (1089) 1089
drug therapy, combination (1051) 1051
aerosols (1023) 1023
salmeterol (998) 998
adrenergic beta-agonists - therapeutic use (975) 975
dose-response relationship, drug (966) 966
adrenergic beta-agonists - pharmacology (882) 882
child, preschool (859) 859
time factors (843) 843
adrenergic beta-agonists - administration & dosage (834) 834
forced expiratory volume (815) 815
pediatrics (794) 794
allergy (785) 785
children (785) 785
drug therapy (755) 755
forced expiratory volume - drug effects (743) 743
fluticasone (711) 711
pulmonary disease, chronic obstructive - drug therapy (684) 684
medicine, general & internal (672) 672
respiratory function tests (670) 670
acute disease (633) 633
bronchodilator agents - pharmacology (632) 632
cross-over studies (631) 631
drug combinations (583) 583
infant (580) 580
immunology (570) 570
research (563) 563
rats (544) 544
formoterol fumarate (543) 543
analysis (515) 515
bronchodilator agents - adverse effects (503) 503
heart rate - drug effects (501) 501
albuterol - chemistry (495) 495
androstadienes - administration & dosage (487) 487
clinical trials as topic (480) 480
critical care medicine (473) 473
in vitro techniques (473) 473
isoproterenol - pharmacology (469) 469
spirometry (466) 466
dosage and administration (461) 461
antiasthmatic agents (460) 460
care and treatment (448) 448
prospective studies (446) 446
therapy (439) 439
androstadienes - therapeutic use (433) 433
severity of illness index (413) 413
drug administration schedule (411) 411
anti-asthmatic agents - therapeutic use (404) 404
asthma - diagnosis (401) 401
respiratory tract diseases (400) 400
administration, oral (399) 399
particle size (397) 397
formoterol (396) 396
albuterol - pharmacokinetics (394) 394
health aspects (393) 393
lung diseases, obstructive - drug therapy (388) 388
anti-asthmatic agents - administration & dosage (381) 381
efficacy (379) 379
copd (378) 378
inhalation (378) 378
corticosteroids (376) 376
peak expiratory flow rate (374) 374
adrenergic beta-agonists - adverse effects (372) 372
guinea pigs (362) 362
bronchi - drug effects (358) 358
ethanolamines - therapeutic use (356) 356
cardiac & cardiovascular systems (354) 354
bronchial provocation tests (348) 348
bronchodilator agents (342) 342
research article (342) 342
ipratropium - therapeutic use (341) 341
chronic obstructive pulmonary disease (333) 333
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (11295) 11295
French (211) 211
German (166) 166
Italian (136) 136
Spanish (120) 120
Japanese (93) 93
Polish (83) 83
Chinese (57) 57
Russian (55) 55
Portuguese (31) 31
Danish (19) 19
Dutch (15) 15
Romanian (12) 12
Croatian (9) 9
Norwegian (8) 8
Swedish (4) 4
Turkish (4) 4
Czech (3) 3
Hebrew (3) 3
Hungarian (3) 3
Serbian (3) 3
Finnish (2) 2
Korean (2) 2
Persian (1) 1
Slovak (1) 1
Slovenian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


American Journal of Respiratory and Critical Care Medicine, ISSN 1073-449X, 10/2004, Volume 170, Issue 8, pp. 836 - 844
Journal Article
Annals of Emergency Medicine, ISSN 0196-0644, 2016, Volume 68, Issue 4, pp. S50 - S50
To link to full-text access for this article, visit this link: http://dx.doi.org/10.1016/j.annemergmed.2016.08.138 Byline: S. Morgan, P. Matthews, M.A. Papas,... 
Emergency | Albuterol
Journal Article
Annals of Emergency Medicine, ISSN 0196-0644, 2015, Volume 66, Issue 4, pp. S136 - S136
Journal Article
Journal of Allergy and Clinical Immunology, The, ISSN 0091-6749, 2011, Volume 128, Issue 2, pp. 315 - 322
Journal Article
Journal of Pharmacology and Experimental Therapeutics, ISSN 0022-3565, 06/2011, Volume 337, Issue 3, pp. 600 - 609
beta(2)-Adrenoceptor (beta(2)-AR) agonists are powerful bronchodilators and play a pivotal role in the management of pulmonary obstructive diseases, such as... 
BETA-ADRENOCEPTOR AGONISTS | FORMOTEROL | OBSTRUCTIVE PULMONARY-DISEASE | ASTHMA | PHARMACOLOGY & PHARMACY | BETA-2-ADRENOCEPTOR AGONIST | SELECTIVITY | BURDEN | BETA-ADRENERGIC RECEPTOR | SALMETEROL | COPD | Adrenergic beta-2 Receptor Agonists - pharmacokinetics | Ethanolamines - pharmacology | Formoterol Fumarate | Bronchodilator Agents - administration & dosage | Albuterol - pharmacology | Humans | Half-Life | Pulmonary Disease, Chronic Obstructive - physiopathology | Ethanolamines - administration & dosage | Adrenergic beta-2 Receptor Agonists - pharmacology | Bronchodilator Agents - chemistry | Ethanolamines - pharmacokinetics | Benzoxazines - pharmacokinetics | Albuterol - administration & dosage | Binding Sites | Benzoxazines - chemistry | Cricetinae | Salmeterol Xinafoate | Benzoxazines - administration & dosage | Adrenergic beta-2 Receptor Agonists - chemistry | Administration, Inhalation | Albuterol - analogs & derivatives | Albuterol - pharmacokinetics | Bronchodilator Agents - pharmacology | Receptors, Adrenergic, beta-1 - metabolism | Ethanolamines - chemistry | Asthma - drug therapy | Receptors, Adrenergic, beta-2 - metabolism | Animals | Bronchodilator Agents - pharmacokinetics | Benzoxazines - pharmacology | Adrenergic beta-2 Receptor Agonists - administration & dosage | Albuterol - chemistry | Mice | Mice, Inbred BALB C | Lipid Bilayers - metabolism | Pulmonary Disease, Chronic Obstructive - drug therapy
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 03/2011, Volume 364, Issue 12, pp. 1093 - 1103
Journal Article
Journal Article
Cochrane Database of Systematic Reviews, ISSN 1469-493X, 2012, Volume 2016, Issue 11, p. CD009157
Background Tiotropium and long‐acting beta2‐agonists (LABAs) are both accepted in the routine management for people with stable chronic obstructive pulmonary... 
Formoterol Fumarate | Costs | Lungs & airways | Indans | Insurance medicine | Quinolones | Muscarinic antagonists | Chronic obstructive pulmonary disease (stable) | Bronchodilators | Albuterol | Scopolamine Derivatives | Cost‐Benefit Analysis | Tiotropium Bromide | Salmeterol Xinafoate | Pulmonary Disease, Chronic Obstructive | Hospitalization | Bronchodilator Agents | Beta‐agonists, long‐acting, twice daily | Ethanolamines | Disease Progression | Randomized Controlled Trials as Topic | Adrenergic beta‐2 Receptor Agonists | Quality of Life | Chronic obstructive pulmonary disease, stable ‐ pharmacotherapy | Medicine General & Introductory Medical Sciences | CHRONIC-BRONCHITIS | BRONCHODILATOR | FORMOTEROL | MEDICINE, GENERAL & INTERNAL | COST-EFFECTIVENESS | TWICE-DAILY SALMETEROL | ONCE-DAILY INDACATEROL | EXACERBATIONS | AIR-FLOW | COPD PATIENTS | HEALTH OUTCOMES | Bronchodilator Agents - therapeutic use | Bronchodilator Agents - economics | Humans | Albuterol - analogs & derivatives | Indans - therapeutic use | Scopolamine Derivatives - economics | Adrenergic beta-2 Receptor Agonists - economics | Cost-Benefit Analysis | Quinolones - therapeutic use | Adrenergic beta-2 Receptor Agonists - therapeutic use | Albuterol - therapeutic use | Ethanolamines - therapeutic use | Albuterol - economics | Scopolamine Derivatives - therapeutic use | Pulmonary Disease, Chronic Obstructive - drug therapy
Journal Article
Chest, ISSN 0012-3692, 11/2008, Volume 134, Issue 5, pp. 981 - 989
Journal Article
CLINICAL PHARMACOKINETICS, ISSN 0312-5963, 02/2020, Volume 59, Issue 2, pp. 257 - 264
Background Intravenous salbutamol is used to treat children with refractory status asthmaticus, however insufficient pharmacokinetic data are available to... 
EARLY MANAGEMENT | TRIAL | ALBUTEROL | (R)-ALBUTEROL | PHARMACOLOGY & PHARMACY | NEBULIZED IPRATROPIUM | (S)-ALBUTEROL | Index Medicus
Journal Article
American Journal of Respiratory and Critical Care Medicine, ISSN 1073-449X, 01/2008, Volume 177, Issue 1, pp. 19 - 26
Journal Article
Cochrane Database of Systematic Reviews, ISSN 1469-493X, 2010, Volume 2010, Issue 5, p. CD005535
Background Long‐acting inhaled ß2‐adrenergic agonists (LABAs) are recommended as 'add‐on' medication to inhaled corticosteroids (ICS) in the maintenance... 
Formoterol Fumarate | Lungs & airways | Adrenal Cortex Hormones | Asthma (chronic): bronchodilators | Anti‐Asthmatic Agents | Combination and additive therapies | Beclomethasone | Asthma (chronic) | Child health | Bronchodilators | Asthma, chronic ‐ pharmacotherapy | Albuterol | Drug Therapy, Combination | Asthma (chronic): combination/additive drug treatment | Salmeterol Xinafoate | Administration, Inhalation | Ethanolamines | Asthma | Randomized Controlled Trials as Topic | Steroids, inhaled | Beta‐agonists, long‐acting | Adrenergic beta‐Agonists | Medicine General & Introductory Medical Sciences | Chronic Disease | Combination/additive drug treatment | Adrenal Cortex Hormones [therapeutic use] | COST-EFFECTIVENESS ANALYSIS | Humans | Adrenergic beta-Agonists [therapeutic use] | SURROGATE INFLAMMATORY MARKERS | MEDICINE, GENERAL & INTERNAL | FLUTICASONE PROPIONATE/SALMETEROL COMBINATION | LEUKOTRIENE RECEPTOR ANTAGONIST | Asthma [drug therapy] | Adult | TWICE-DAILY TREATMENT | SALMETEROL/FLUTICASONE PROPIONATE COMBINATION | FORMOTEROL OXIS(R) TURBUHALER(R) | QUALITY-OF-LIFE | MILD PERSISTENT ASTHMA | Child | Anti-Asthmatic Agents [therapeutic use] | ONCE-DAILY BUDESONIDE | Beclomethasone - administration & dosage | Albuterol - analogs & derivatives | Child, Preschool | Asthma - drug therapy | Ethanolamines - administration & dosage | Drug Therapy, Combination - methods | Adolescent | Adrenergic beta-Agonists - administration & dosage | Albuterol - administration & dosage | Anti-Asthmatic Agents - administration & dosage | Adrenal Cortex Hormones - administration & dosage
Journal Article